The Gulf War era multiple sclerosis cohort: Age and incidence rates by race, sex and service

Brain

Volumn 135, Issue 6, 2012, Pages 1778-1785

  Wallin, Mitchell T ^a,b,c   Culpepper, William J ^c,d   Coffman, Parisa ^a   Pulaski, Sarah ^a   Maloni, Heidi ^a,c   Mahan, Clare M ^e   Haselkorn, Jodie K ^c,e,f   Kurtzke, John F ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA Multiple Sclerosis Centres of Excellence   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

age at onset; demyelinating disease; epidemiology; multiple sclerosis; sex differences

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MILITARY SERVICE; MORBIDITY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; ONSET AGE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; UNITED STATES; WAR;

EID: 84861557045     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws099     Document Type: Article

References (41)

1. Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 1992; 31: 333-6.
2. Armed Forces Health Surveillance Center (AFHSC) 2011. http://afhsc.mil. (1 February 2012, date last accessed).
3. Baum HM, Rothschild BB. The incidence and prevalence of reported multiple sclerosis. Ann Neurol 1981; 10: 420-8.
4. Culpepper WJBD, Bever C, Bourdette D. Epidemiologic description of VA multiple sclerosis surveillance registry. Int J MS Care 2008; 10 (Suppl 1): S15.
5. Culpepper WJ II, Ehrmantraut M, Wallin MT, Flannery K, Bradham DD. Veterans Health Administration multiple sclerosis surveillance registry: the problem of case-finding from administrative databases. J Rehabil Res Dev 2006; 43: 17-24.
6. Davenport C. Multiple sclerosis from the standpoint of geographic distribution and race. Proc ARNMD 1922; 2: 8-19.
7. Dean G. How many people in the world have multiple sclerosis? Neuroepidemiology 1994; 13: 1-7.
8. Defense Medical Surveillance System. Person years for selected population strata, calendar years 1990-2000.
9. DMSS. Defense Medical Surveillance System. Person years for selected population strata, calendar years 2001-2010.
10. DMSS. Department of Defense Demographics. 2004 Demographics (Military Community and Family Policy). Washington, DC: Office of the Deputy Under Secretary of Defense 2004.
11. Deussing E. Multiple sclerosis, active component, U.S. Armed Forces 2000-2009. MSMR 2011; 18,12-5.
12. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-77.
13. Elhami SR, Mohammad K, Sahraian MA, Eftekhar H. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011; 36: 141-7.
14. Hernan MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999; 53: 1711-8.
15. Houzen H, Niino M, Hata D, Nakano F, Kikuchi S, Fukazawa T, et al. Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler 2008; 14: 887-92.
16. Hyams KC, Hanson K, Wignall FS, Escamilla J, Oldfield EC III. The impact of infectious diseases on the health of U.S. troops deployed to the Persian Gulf during operations Desert Shield and Desert Storm. Clin Infect Dis 1995; 20: 1497-504.
17. Kerrison JB, Lounsbury D, Thirkill CE, Lane RG, Schatz MP, Engler RM. Optic neuritis after anthrax vaccination. Ophthalmology 2002; 109: 99-104.
18. Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 1999; 5: 293-6.
19. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 9: 520-32.
20. Kurtzke JF. Neurologic impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand 1970; 46: 493-512.
21. Kurtzke JF. Data registries on selected segments of the population: Veterans. Adv Neurol 1978; 19: 55-67.
22. Kurtzke JF. Some contributions of the Department of Veterans Affairs to the epidemiology of multiple sclerosis. Mult Scler 2008; 14: 1007-12.
23. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology 1979; 29: 1228-35.
24. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003; 61: 1373-7.
25. McElroy JP, Cree BA, Caillier SJ, Gregersen PK, Herbert J, Khan OA, et al. Refining the association of MHC with multiple sclerosis in African Americans. Hum Mol Genet 2010; 19: 3080-8.
26. MMWR. Quitting smoking among adults-United States 2001-2010. MMWR Morb Mortal Wkly Rep, 2011, 60, 1513-9.
27. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-8.
28. Neuberger JS, Lynch SG, Sutton ML, Hall SB, Feng C, Schmidt WR. Prevalence of multiple sclerosis in a residential area bordering an oil refinery. Neurology 2004; 63: 1796-802.
29. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002; 58: 136-8.
30. Noonan CW, Williamson DM, Henry JP, Indian R, Lynch SG, Neuberger JS, et al. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis 2009; 7: 1-8.
31. Owens GP, Gilden D, Burgoon MP, Yu X, Bennett JL. Viruses and multiple sclerosis. Neuroscientist 2011; 17: 659-76.
32. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-6.
33. Ramagopalan SV, Ebers GC. Epistasis: multiple sclerosis and the major histocompatibility complex. Neurology 2009; 72: 566-7.
34. Research Directorate. Defense Equal Opportunity Management Institute. Semiannual race/ethnicity/gender profile by service/rank of the Department of Defense and U.S. Coast Guard. September 2000.
35. Research Directorate. Defense Equal Opportunity Management Institute. Annual demographic profile of the Department of Defense and U.S. Coast Guard. Fiscal Year 2007.
36. Riise T, Moen BE, Kyvik KR. Organic solvents and the risk of multiple sclerosis. Epidemiology 2002; 13: 718-20.
37. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
38. Wallin MT. Integrated multiple sclerosis care: new approaches and paradigm shifts. J Rehabil Res Dev 2010; 47: ix-xiv.
39. Wallin MT, Page WF, Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004; 55: 65-71.
40. Wallin MT, Page WF, Kurtzke JF. Migration and multiple sclerosis in Alaskan military veterans. J Neurol 2009; 256: 1413-7.
41. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.